Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,100
Closed -$4.5M 2199
2025
Q2
$4.5M Sell
16,100
-800
-5% -$227K 0.01% 1092
2025
Q1
$5.27M Sell
16,900
-800
-5% -$236K 0.01% 1003
2024
Q4
$4.61M Sell
17,700
-6,400
-27% -$1.9M 0.01% 1045
2024
Q3
$7.77M Buy
24,100
+10,100
+72% +$3.3M 0.02% 848
2024
Q2
$4.37M Buy
14,000
+9,500
+211% +$2.79M 0.01% 1051
2024
Q1
$1.28M Buy
4,500
+2,500
+125% +$732K ﹤0.01% 1463
2023
Q4
$576K Buy
+2,000
New +$545K ﹤0.01% 1630

Other funds holding AMGN

Man Group's AMGN Position: Q2 2026 in Review

Man Group increased its Amgen (AMGN) stake by 64% in Q2 2026, buying an estimated $31.3M and bringing the position to 234,023 shares worth $84.7M. The position accounts for 0.14% of the portfolio, ranked #178.

Man Group first reported a position in AMGN in Q1 2018 and has held it in 31 quarters since. The position peaked at $244M in Q3 2018. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Man Group held 234,023 shares of Amgen worth $84.7M as of Q2 2026.
  • Man Group bought 91,498 Amgen shares in Q2 2026, an estimated $31.3M.
  • Amgen made up 0.14% of Man Group's portfolio in Q2 2026, its #178 holding.
  • Man Group first reported a position in Amgen in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Amgen position peaked at $244M in Q3 2018.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.